BAC vs JANX · P/E 13, rev $31.56B vs rev $10.3M
Bank of America Corp (BAC) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported BAC revenue for 2026-06-30 was $31.56B. Net income was $9.07B. Revenue was up 4.2% from 2026-03-31 to 2026-06-30. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
BAC currently screens at market cap $382.01B and trailing P/E 13.4. JANX currently screens at market cap $1.49B.
Not investment advice. Open the BAC and JANX stock pages for the full models.
Not investment advice.